HRT FINANCIAL LP

Position in MDXG — Mimedx Group, Inc.

CIK 1475597 NEW YORK, NY

Position in MDXG

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,171,584

+$828,529 QoQ

Shares Held

564,048

+65.9% QoQ

Ownership

0.387%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#30

of 226 holders

Holding Since

Mar 2021

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HRT FINANCIAL LP holds $857,639,414 across 185 Biotechnology names. MDXG ranks #52 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BBIO	BridgeBio Pharma, Inc.	1,089,376	$81,136,724
2	INSM	INSMED Inc	689,981	$73,565,774
3	EXEL	Exelixis, Inc.	929,242	$50,560,057
4	MDGL	Madrigal Pharmaceuticals, Inc.	84,634	$45,444,226
5	AXSM	Axsome Therapeutics, Inc.	178,491	$43,689,242
6	ARWR	Arrowhead Pharmaceuticals, Inc.	498,655	$40,645,369
7	ABVX	Abivax S.A.	270,612	$36,061,755
8	TGTX	Tg Therapeutics, Inc.	622,603	$34,205,808

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,171,584	564,048	+65.9%	Shares	Defined	2026-08-14
2026-03-31	$1,343,055	340,014	+14.6%	Shares	Defined	2026-05-14
2025-12-31	$2,008,327	296,651	+99.0%	Shares	Defined	2026-02-12
2025-09-30	$1,040,697	149,097	+822.1%	Shares	Defined	2025-11-14
2023-12-31	$141,802	16,169	-50.6%	Shares	Defined	2024-02-09
2023-06-30	$216,186	32,706	+16.2%	Shares	Defined	2023-08-11
2022-03-31	$132,595	28,152	+108.9%	Shares	Defined	2022-05-16
2021-12-31	$81,407	13,478	-45.9%	Shares	Defined	2022-02-14
2021-09-30	$150,954	24,910	-11.7%	Shares	Defined	2021-11-15
2021-03-31	$290,666	28,220	—	Shares	Defined	2021-05-17
No filing history on record for this holder in this stock.